why choose us

First received: September 03, 2023

Clinical Trial: Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatocellular Carcinoma

Study Type: INTERVENTIONAL


Official Title: Pharmacogenetic Study of Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.

Brief Summary: This study aims to determine the predictive effect of ATG10 and IL6 genetic polymorphisms in safety and efficacy of sorafenib used for the treatment of Egyptian HCC patients.Moreover, this study will determine the association between genetic polymorphisms of ATG10 and IL6 with HCC severity.

Read more